INHCAP: A Promising Drug Target / Biomarker (G100129696)

Target Name: INHCAP

NCBI ID: G100129696

INHCAP

Other Name(s): TFP1 | inhibitor of carbonic anhydrase pseudogene | TFP | Transferrin pseudogene 1

INHCAP: A Promising Drug Target / Biomarker

INHCAP is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a key regulator of the blood-brain barrier, which is a specialized barrier that separates the brain from the rest of the body and helps to protect it from harmful substances. INHCAP plays a crucial role in maintaining the integrity of the blood-brain barrier, allowing it to selectively allow certain substances to enter the brain while keeping others out.

The blood-brain barrier is a highly specialized barrier that is designed to protect the brain from harmful substances that could cause harm. It is made up of multiple layers of specialized cells, including endothelial cells, which form the lining of the blood vessels, and brain endothelial cells, which line the blood vessels in the brain. These cells are specialized to selectively allow certain substances to enter the brain while keeping others out.

INHCAP is a key regulator of the blood-brain barrier. It is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a structural protein that is made up of multiple domains, including an N-terminus, a transmembrane region, and an C-terminus.

The N-terminus of INHCAP is a region that is involved in the interaction with other proteins. The transmembrane region is responsible for the protein's localization and stability, while the C-terminus is involved in its interactions with other proteins and the extracellular matrix.

INHCAP is involved in many different processes in the body. It is a key regulator of the blood-brain barrier, which is a specialized barrier that separates the brain from the rest of the body and helps to protect it from harmful substances. INHCAP plays a crucial role in maintaining the integrity of the blood-brain barrier, allowing it to selectively allow certain substances to enter the brain while keeping others out.

In addition to its role in the blood-brain barrier, INHCAP is also involved in many other processes in the body. It is a key regulator of the immune system, helping to protect the body against harmful substances that could cause disease. It is also involved in the regulation of inflammation, helping to reduce inflammation and promote healing.

INHCAP is a protein that is expresses in various tissues of the body, including the brain, heart, kidneys, and liver. It is a key regulator of the blood-brain barrier, which is a specialized barrier that separates the brain from the rest of the body and helps to protect it from harmful substances. INHCAP plays a crucial role in maintaining the integrity of the blood-brain barrier, allowing it to selectively allow certain substances to enter the brain while keeping others out.

Conclusion

INHCAP is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a key regulator of the blood-brain barrier, which is a specialized barrier that separates the brain from the rest of the body and helps to protect it from harmful substances. INHCAP plays a crucial role in maintaining the integrity of the blood-brain barrier, allowing it to selectively allow certain substances to enter the brain while keeping others out. Further research is needed to fully understand the role of INHCAP in the regulation of the immune system and inflammation.

Protein Name: Inhibitor Of Carbonic Anhydrase Pseudogene

The "INHCAP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about INHCAP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets